中国2型糖尿病初级保健患者收缩压访视间变异性与心血管疾病及死亡风险的关联:一项回顾性人群队列研究
该回顾性队列研究纳入124105例无既往心血管疾病的中国成人2型糖尿病初级保健患者,随访中位39.5个月,评估24个月内收缩压标准差所代表的访视间变异性。收缩压变异性与心血管疾病及全因死亡风险呈正线性相关,收缩压标准差每增加1个标准差,心血管疾病、全因死亡及复合终点风险分别增加2.9%、4.0%和3.4%。
要点
- 收缩压标准差<5 mmHg者心血管疾病和全因死亡风险最低。
- 收缩压标准差每增加1个标准差,心血管疾病风险增加2.9%(95%CI 2.4-3.4%)。
- 收缩压变异性是心血管疾病和全因死亡的潜在预测因素,与平均收缩压水平无关。
核心结论
- 收缩压变异性与心血管疾病及全因死亡风险呈正线性关系,且该关系独立于平均收缩压水平。
- 收缩压变异性是糖尿病患者发生心血管疾病和全因死亡的潜在预测因素。
- 临床医生除监测血压目标外,还应警惕血压的访视间波动。
研究设计与样本
- 回顾性人群队列研究,纳入2008年8月至2009年12月期间124105例无既往确诊心血管疾病的中国成人2型糖尿病初级保健患者。
- 采用24个月内收缩压的标准差评估访视间变异性,使用Cox比例风险回归评估风险,并按年龄、性别、糖尿病病程、慢性肾病、基线收缩压及趋势、降压药数量和类别进行亚组分析。
主要发现
- 中位随访39.5个月,收缩压变异性与首次心血管疾病发生及全因死亡呈正线性关系。
- 收缩压标准差<5 mmHg的患者心血管疾病和全因死亡风险最低,收缩压标准差≥10 mmHg的患者风险显著更高。
- 收缩压标准差每增加1个标准差,心血管疾病风险增加2.9%(95%CI 2.4-3.4%),全因死亡风险增加4.0%(95%CI 3.5-4.6%),复合终点风险增加3.4%(95%CI 3.0-3.8%)。
- 所有选定亚组中均观察到直接线性关系。
临床怎么用
- 原文结论指出,临床医生除监测糖尿病患者的血压目标外,还应保持对血压访视间波动的警惕。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to evaluate the impact of visit-to-visit variability (VVV) of systolic blood pressure (SBP) on cardiovascular disease (CVD) and mortality among primary care Chinese patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: A retrospective cohort study was conducted in 124,105 Chinese adult primary care patients with T2DM and without prior diagnosed CVD from August 2008 to December 2009. The VVV of SBP was evaluated using SDs of SBP over 24 months. The risks of CVD and all-cause mortality associated with variability in SBP were evaluated using Cox proportional hazards regression. Subgroup analysis was conducted by the stratification of age, sex, duration of diabetes, the presence of chronic kidney disease, baseline SBP and trend, and the number and class of antihypertensive drugs. RESULTS: A positive linear relationship between the VVV of SBP and the first incidence of CVD and all-cause mortality was identified over a median follow-up time of 39.5 months. Patients with a low SD of SBP of <5 mmHg had the lowest risks of CVD and all-cause mortality, and patients with an SD of SBP of ≥10 mmHg had significantly higher risks. For every 1 SD increase in the SD of SBP, the risks of CVD, all-cause mortality, and the composite of both events increased by 2.9% (95% CI 2.4-3.4%), 4.0% (95% CI 3.5-4.6%), and 3.4% (95% CI 3.0-3.8%), respectively. A direct linear relationship was also observed in all selected subgroups. CONCLUSIONS: SBP variability, irrespective of the mean SBP level, is a potential predictor for the development of CVD and all-cause mortality in patients with diabetes. In addition to monitoring BP targets for their patients with diabetes, clinicians should also remain vigilant about the visit-to-visit fluctuation of BP.
引用
- Wan EY, Fung CS, Yu EY, et al. Association of Visit-to-Visit Variability of Systolic Blood Pressure With Cardiovascular Disease and Mortality in Primary Care Chinese Patients With Type 2 Diabetes-A Retrospective Population-Based Cohort Study. Diabetes Care. 2016. PMID: 27899498. doi:10.2337/dc16-1617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。